Don’t forget to RSVP for the Pharmaceuticals Program Symposium happening this Friday, Feb. 28th!
February 28th is right around the corner and so is the BUSPH Pharmaceutical symposium! Come join us in Bakst Auditorium between 1 pm and 7 pm for exciting panel discussions about the changing financial landscape in the pharmaceutical industry, domestically and abroad.
Our speakers include:
Panel 1 (domestic):
Dr. Doug Williams, Executive Vice President, Research & Development, Biogen
Dr. Josh Cohen, Deputy Director of the Center for the Evaluation of Value and Risk in Health, and Associate Professor at Tufts Medical Center
Dr. Alan Sager, Professor, Health Policy & Management, BUSPH
Krista Rubin, Nurse Practitioner, Dana Farber
Dr. Chris Sanders, Chief Information Officer, Millennium
Panel 2 (international):
Dr. Ted Haack, Head of Market Access, Rare Diseases, Genzyme
Dr. Doug Keene, Vice President of the Center for Pharmaceutical Management, Management Sciences for Health
Dr. Veronika Wirtz, Associate Professor, International Health, BUSPH
Dr. Muhammad Zaman, Associate Professor, Biomedical Engineering, BU Engineering
Dr. Tom McKeeff, Business Analyst, Sproxil
Dr. Dennis Ross-Degnan, Associate Professor at Harvard Medical School, and Director of Research at Harvard Pilgrim Health Care
Scheduling details
1:00-1:20 introductory remarks
1:20-3:20 panel 1 discussing the domestic issues
3:20-3:50 coffee break
3:50-5:50 panel 2 discussing the international issues
5:50-6:00 concluding remarks
6:00-7:00 networking
To register for this event or to learn more please visit our eventbrite page.
For more questions please don’t hesitate to send an email to the co-chairs Evelyn Koh or Madeleine Kuhn.
